Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy
对于激素受体和HER2阳性的绝经前乳腺癌患者，辅助性卵巢功能抑制和芳香化酶抑制剂治疗，根据化疗和曲妥珠单抗的时机以及对新辅助治疗的反应进行评估
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104669
Shai, Ayelet; Wildiers, Hans; Venieri, Claudio; Pogoda, Katarzyna; Linderholm, Barbro; Lambertini, Matteo; Matos, Leonor; De Maio D'Esposito, Eleonora; Hajjaji, Nawale; Matos, Erika; González Cortijo, Lucía; Fotia, Giuseppe; Fortuna, Ana; Sella, Tal; Gouveia, Helena; Rosset, Laurent; Constantinidou, Anastasia; Angeli, Eurydice; Cicin, Irfan; Tjan-Heijnen, Vivianne; Ruyssers, Natacha; Demasure, Sofie; Abu Remilah, Areen; Huygh, Greet; Paluch-Shimon, Shani; Chiappe, Edoardo; Shirron, Natali; Neven, Patrick; Artac, Mehmet; Kilictas, Bilgesah; Baranseh, Jalal; Vicente-Rubio, Elena; Atci, Mustafa; Amato, Ottavia; van Duijnhoven, Frederieke
